Press release
AmeraCell Partners with StemWave to Offer Innovative Pain Management Solutions
Fairfax, VA - AmeraCell, a leading provider of life science medicines, is pleased to announce that it has signed a Letter of Intent (LOI) with StemWave, a pioneering provider of non-invasive pain management solutions.
This strategic partnership aims to provide patients with cutting-edge regenerative medicine solutions for pain management, leveraging the expertise of both organizations.
"We are thrilled to partner with StemWave to offer our patients innovative pain management options," said Dr. Doki, Chief Medical Officer of AmeraCell. "This partnership reflects our commitment to providing the most advanced and effective treatments for pain management in Fairfax, Virginia."
"AmeraCell is proud to collaborate with StemWave, a respected leader in pain management," said AJ Pakpour, Founder of AmeraCell. "Together, we will work to improve the lives of patients suffering from chronic pain, offering them new hope and innovative solutions utilizing StemWave therapy in conjunction with our MSC and Exosomes products."
The partnership will enable both organizations to expand their services, providing patients with access to a broader range of regenerative medicine solutions, including stem cell injections and stem cell IV treatments in Fairfax Virginia.
About AmeraCell
AmeraCell is a leading provider of life science medicines with multiple national locations, dedicated to improving the lives of patients through innovative and effective treatments, one cell at a time.
About StemWave
StemWave therapy is a non-invasive treatment that uses acoustic wave technology to stimulate the body's natural healing processes. It is also known as shock wave therapy.
StemWave therapy delivers high-energy sound waves to the affected area, promoting:
- Increased blood flow
- Improved cell regeneration
- Reduced inflammation
Conditions Treated:
StemWave therapy is commonly used to treat musculoskeletal conditions such as:
- Chronic pain
- Plantar fasciitis
- Tendinitis
- Arthritis
- Osteoporosis
Note to editors:
- High-resolution images and interviews with Dr. Doki and AJ Pakpour are available upon request.
- For more information about AmeraCell, please visit
AmeraCell.com
AmeraCellClinics@Gmail.com
407 801 2269
Media Contact
Company Name: AmeraCell
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=ameracell-partners-with-stemwave-to-offer-innovative-pain-management-solutions]
Address:3022 Williams Dr
City: Fairfax
State: Virginia 22031
Country: United States
Website: https://ameracell.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release AmeraCell Partners with StemWave to Offer Innovative Pain Management Solutions here
News-ID: 3872506 • Views: …
More Releases from ABNewswire
Global Sound Reinforcement Market Set to Grow at 4.28% CAGR, Reaching USD 38.58 …
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2025-2030.
The global sound reinforcement market [https://www.arizton.com/market-reports/sound-reinforcement-market-size-growth] is projected to expand from USD 30 billion in 2024 to USD 38.58 billion by 2030, growing at a steady 4.28% CAGR, according to Arizton. This growth is being driven by rising demand for high-quality audio solutions across live events and entertainment venues. Advances in audio technology have significantly enhanced…
Gelt Raises $13M Series A to Expand AI-Powered Tax Solutions for Real Estate Inv …
Miami, FL - September 30, 2025 - Gelt [https://www.joingelt.com/], the first AI-native tax firm for investors and the Top 1% in the U.S., today announced it has raised $13 million in Series A [https://www.businesswire.com/news/home/20250930325477/en/Gelt-the-First-AI-Native-Tax-Firm-Raises-%2413M-in-Series-A-Funding-to-Transform-Tax-Strategy-Into-Year-Round-Wealth-Optimization], bringing its total funding to $21.2 million. Global investors, Zvi Limon of the Rimon Group, Vintage Investment Partners, and TLV Partners led the funding. As part of the launch, Yoram Tietz, former Managing Partner at EY…
Applications of 5-50mm security camera lens
The application scenarios of 5-50 mm surveillance lenses are primarily categorized according to the variations in field of view resulting from changes in focal length. The specific applications are as follows:
1. Wide-angle range (5-12 mm)
Panoramic monitoring for confined spaces A focal length of 5-8 mm (with a field of view of 60 degrees -90 degrees ) is suitable for enclosed small areas within 5 times 5 meters, such as elevator…
Daniel Smart Manufacturing Empowers Riders with their New Custom Builder Feature …
A leather jacket [https://danielsmartmfg.com/collections/mens-leather-motorcycle-jackets] for a rider is an essential part of their ride, and it makes them feel incomplete without it whenever they hit the road. If you are a biker, you must know what it means. Now imagine you can design your leather jacket your way, which may further enhance your experience on the road. Well, Daniel Smart, a renowned brand in the leather jacket industry, is now…
More Releases for AmeraCell
AmeraCell Launches Revolutionary Wharton's Jelly MSc IV Therapy for Advanced Wel …
Image: https://www.abnewswire.com/upload/2025/01/9c6215166ea166a615398ac58e4d78ef.jpg
Fairfax, Virginia - AmeraCell [https://ameracell.com/], a Life Science Clinic, is proud to announce the launch of its groundbreaking Wharton's Jelly MSc IV therapy. This innovative treatment utilizes the regenerative power of Wharton's jelly, cellular solutions, and mesenchymal cells to enhance overall wellness and address various chronic health conditions.
Wharton's Jelly MSc therapy is derived from ethically sourced umbilical cords. It is rich in Wharton's jelly, growth factors, and other bioactive…
AmeraCell Bio Hacking with Wharton's Jelly IV Therapy
Image: https://www.abnewswire.com/upload/2025/01/4403872202ee73139f40540774e54535.jpg
Fairfax Virginia - AmeraCell, [https://ameracell.com/]a leading provider of regenerative medicine solutions, is proud to announce the launch of its innovative Wharton's Jelly IV therapy. This groundbreaking treatment harnesses the power of mesenchymal stem cells (MSCs), cellular solutions, and exosomes to promote overall wellness and address various health conditions.
About Wharton's Jelly IV Therapy
Wharton's Jelly, a gelatinous substance extracted from umbilical cords, is rich in MSCs, growth factors, and other beneficial…
AmeraCell Appoints Renowned Oncologist and Hematologist, Naveen Doki, MD, as Chi …
Image: https://lh7-rt.googleusercontent.com/docsz/AD_4nXf6lnWBjHtv1vNESJODCnyAI57Da6r_Bsny_CRL1HkRArIePBqhfHdc8E-3Mgv1srSjvPOZ0kOPN5esunTJVx31kwbLHZ4FGlGNuQxjEUfHP-Zx61Epyfu5917VDsN1YeM0FvdySA?key=pfjRRuJ_S4XBBGPHHK1PXqNz
New York New York - AmeraCell [https://ameracell.com/], a cutting-edge life science company, announced today the appointment of Naveen Doki, MD, as its Chief Medical Officer (CMO). Dr. Doki brings over a decade of experience in oncology and hematology from the DC Metro area to his new role.
As CMO, Dr. Doki will spearhead the development and implementation of AmeraCell's medical strategies, ensuring the company remains at the forefront of regenerative…
AmeraCell Solidifies Leadership in Life Sciences with Plans for Innovation and E …
Image: https://www.abnewswire.com/upload/2025/01/362d0397e292acf147cd220e0ad40f81.jpg
Washington, D.C. - January 2, 2025 - AmeraCell [https://ameracell.com/], a pioneering name in the life sciences sector, is proud to announce its continued success in 2024, solidifying its reputation as an industry leader. With a network of eight strategic locations across the United States, AmeraCell continues to redefine healthcare innovation and deliver exceptional patient outcomes. The company remains dedicated to improving lives through groundbreaking health solutions and personalized care.
Reflecting…
AmeraCell Accessible Affordable Bio Hacking in Katy Texas an American Life Scien …
Image: https://www.abnewswire.com/uploads/c46306625cd5028d1dcf9ba4de05042c.png
Katy, TX - AmeraCell, a pioneering life science company, is thrilled to announce its expansion into Katy, Texas. This strategic move marks a significant milestone in AmeraCell's mission to democratize access to innovative, life-changing therapies.
AmeraCell's Katy location will offer a comprehensive range of life science solutions, including:
- Bio-Hacking: Personalized wellness programs leveraging cutting-edge technology and medical expertise
- Stem Cell Therapy: MSC stem cell joint injections and IV hydration treatments…
AmeraCell Bio Hacking in Katy, Texas with Cutting-Edge Life Science Solutions
Image: https://www.abnewswire.com/uploads/79e38f5d5a8c3789b9f55057ecaf6d44.png
Katy, TX - AmeraCell, a pioneering life science company, is thrilled to announce its expansion into Katy, Texas. This strategic move marks a significant milestone in AmeraCell's mission to democratize access to innovative, life-changing therapies.
AmeraCell's Katy location will offer a comprehensive range of life science solutions, including:
- Bio-Hacking: Personalized wellness programs leveraging cutting-edge technology and medical expertise
- Stem Cell Therapy: MSC stem cell joint injections and IV hydration treatments…
